Star Health & Allied Insurance Company Ltd is Rated Hold

Current Rating and Its Significance

The 'Hold' rating assigned to Star Health & Allied Insurance Company Ltd indicates a neutral stance for investors. It suggests that while the stock is not currently a strong buy, it also does not warrant a sell recommendation. Investors are advised to maintain their existing positions and monitor the company’s performance closely. This rating reflects a balanced view of the company’s prospects, considering both its strengths and areas of caution.

Quality Assessment

As of 02 August 2026, the company’s quality grade is assessed as average. This evaluation considers the firm’s operational efficiency, profitability, and management effectiveness. Star Health has demonstrated strong long-term fundamental strength, with a compound annual growth rate (CAGR) of 19.64% in operating profits. This robust profit growth underscores the company’s ability to generate earnings consistently over time, a positive indicator for investors seeking stability.

However, the company faces challenges in net sales growth, which has declined at an annual rate of -48.82%. This contraction in sales volume tempers the overall quality assessment, signalling potential headwinds in expanding its top line. Investors should weigh this mixed quality profile when considering the stock’s future trajectory.

Valuation Considerations

Valuation remains a critical factor in the current rating. Star Health & Allied Insurance is classified as very expensive, trading at a price-to-book (P/B) ratio of 4.7, which is significantly higher than its peers’ average historical valuations. This premium valuation reflects market optimism but also raises concerns about the stock’s price sustainability.

The company’s return on equity (ROE) stands at 11.3%, which, while respectable, does not fully justify the elevated valuation multiples. Additionally, the price/earnings to growth (PEG) ratio is 4.1, indicating that the stock’s price growth expectations are high relative to its earnings growth. For investors, this suggests caution, as the stock may be vulnerable to valuation corrections if growth expectations are not met.

Financial Trend Analysis

Financially, Star Health & Allied Insurance shows a positive trend. The latest quarterly results for June 2026 highlight record-breaking figures, with net sales reaching ₹5,522.07 crores and PBDIT (profit before depreciation, interest, and taxes) hitting ₹749.21 crores. The operating profit margin relative to net sales also peaked at 13.57%, signalling improved operational efficiency.

Over the past year, the stock has delivered a market-beating return of 35.17%, substantially outperforming the BSE500 index return of 1.95%. Profit growth over the same period was 10.3%, indicating that earnings are rising, albeit at a slower pace than the stock price. This divergence between price appreciation and profit growth is a key consideration for investors evaluating the sustainability of returns.

Technical Outlook

From a technical perspective, the stock is currently rated bullish. Recent price movements show positive momentum, with gains of 3.32% over the past week and 14.39% over three months. The six-month and year-to-date returns are also strong at 27.96% and 32.05%, respectively. Despite a slight dip of 1.35% on the day of analysis, the overall technical indicators suggest continued investor interest and buying pressure.

High institutional holdings at 35.45% further reinforce confidence in the stock’s technical outlook. Institutional investors typically possess greater analytical resources and tend to support stocks with solid fundamentals and growth prospects. Their significant stake in Star Health indicates a level of endorsement that may provide price support in volatile markets.

Here's How the Stock Looks TODAY

As of 02 August 2026, Star Health & Allied Insurance Company Ltd presents a mixed but cautiously optimistic picture. The company’s strong operating profit growth and record quarterly results highlight its operational strengths. However, the very expensive valuation and declining net sales growth warrant a measured approach.

Investors should consider the 'Hold' rating as a signal to maintain current positions rather than initiate new ones or exit holdings. The stock’s bullish technical stance and institutional backing provide some reassurance, but the premium valuation and sales contraction suggest that upside potential may be limited in the near term.

Investor Takeaway

For investors, the 'Hold' rating on Star Health & Allied Insurance Company Ltd suggests a prudent stance. The company’s operational performance and technical momentum are encouraging, but the elevated valuation and sales decline introduce risk factors that cannot be ignored. Maintaining existing holdings while monitoring quarterly results and market conditions is advisable.

Potential investors should await clearer signs of sustained sales growth or valuation moderation before committing fresh capital. Meanwhile, those already invested can benefit from the company’s strong profit growth and market-beating returns, but should remain vigilant to any shifts in fundamentals or market sentiment.

Summary of Key Metrics as of 02 August 2026

Market Capitalisation: Smallcap segment
Mojo Score: 64.0 (Hold)
Quality Grade: Average
Valuation Grade: Very Expensive
Financial Grade: Positive
Technical Grade: Bullish
Institutional Holdings: 35.45%
1-Year Stock Return: +35.17%
BSE500 1-Year Return: +1.95%
ROE: 11.3%
Price to Book Value: 4.7
PEG Ratio: 4.1

These figures collectively underpin the current 'Hold' rating, reflecting a stock with solid profit growth and technical strength but tempered by valuation concerns and sales contraction.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →